Clinical Trial: A Randomized Controlled Study Comparing Low-dose Radiotherapy Combined With Target-free Therapy Versus Target-free Therapy Alone in Neoadjuvant Treatment for Resectable Head and Neck Squamous Cell Carcinoma.

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804850) titled 'A Randomized Controlled Study Comparing Low-dose Radiotherapy Combined With Target-free Therapy Versus Target-free Therapy Alone in Neoadjuvant Treatment for Resectable Head and Neck Squamous Cell Carcinoma.' on Jan. 27.

Brief Summary: To compare the efficacy of low-dose radiotherapy combined with target-free therapy versus target-free therapy alone in neoadjuvant therapy for patients with resectable head and neck squamous cell carcinoma.

Study Start Date: Feb. 14

Study Type: INTERVENTIONAL

Condition: Head and Neck Cancer

Intervention: DRUG: Tislelizumab

200mg IV Q3W

DRUG: Afatinib

30mg PO QD

RADIATION: Low dose radiotherap...